This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Ngm Biopharmaceuticals, Inc.. Active years: 2021-2023.
Company Filing History:
Years Active: 2021-2023
Title: Jared Martin Higbee: Innovator in Biopharmaceuticals
Introduction
Jared Martin Higbee is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of binding agents that target complement component C3. With a total of 2 patents to his name, Higbee's work is paving the way for advancements in therapeutic applications.
Latest Patents
Higbee's latest patents include innovative technologies such as C3-binding agents and methods of use thereof. This patent provides binding agents, including antibodies, that specifically bind to human complement component C3. The disclosure also encompasses related polynucleotides and vectors encoding these binding agents. Another significant patent is for anti-C3 antibodies, which similarly focuses on binding agents that target complement component C3, along with their compositions and methods of use.
Career Highlights
Jared Martin Higbee is currently employed at NGM Biopharmaceuticals, Inc., where he continues to push the boundaries of biopharmaceutical research. His work is instrumental in developing new therapeutic strategies that could potentially improve patient outcomes.
Collaborations
Higbee collaborates with talented professionals in his field, including Dana Yen Mei Duey and Zhonghao Liu. These collaborations enhance the innovative potential of his research and contribute to the success of their projects.
Conclusion
Jared Martin Higbee is a prominent figure in the biopharmaceutical industry, with a focus on complement component C3. His patents and ongoing work at NGM Biopharmaceuticals, Inc. highlight his commitment to advancing medical science.